Background: Coronary heart disease angina pectoris is a clinical syndrome in which episodic chest pain or chest discomfort is the main manifestation of temporary ischemia and hypoxia of the myocardium due to coronary atherosclerosis and coronary artery functional changes (spasm).
A large amount of clinical evidence confirms that acupuncture combined with Chinese herbal medicine in the treatment of coronary heart disease and angina pectoris can relieve the symptoms of angina pectoris and improve the performance of electrocardiograph ischemia; It still has obvious therapeutic effects in regulating the levels of cardiovascular regulatory peptides ET and cGRP. To better evaluate the effectiveness and safety of acupuncture combined with Chinese herbal medicine in the treatment of coronary heart disease and angina pectoris, we designed a systematic evaluation program to provide a reliable scientific basis for the future use of this method.
Methods: Search Pubmed database, Embase, Cochrane library, Chinese Biomedical Literature CD-ROM Database (CBMdisk), China Journal Network Full-text Database (CNKI), Wanfang Database, Web of Science (SCI-E), the retrieval time is established from each database Until October 2021, search for relevant eligible randomized controlled trials with keywords or subject terms “acupuncture”, “Chinese herbal medicine”, and “CHD angina”. Outcome indicators were clinical symptoms of coronary heart disease and angina pectoris, changes in electrocardiogram, changes in blood lipids, and significant improvement in traditional Chinese medicine syndromes before and after treatment. Two researchers independently carried out data extraction and quality assessment, and use RevMan5.3 software to carry out final data analysis and assessment.
Results: This study provides a reliable clinical scientific basis for acupuncture combined with Chinese herbal medicine for the treatment of coronary heart disease and angina pectoris.
Conclusion: Acupuncture combined with Chinese herbal medicine can effectively relieve the clinical symptoms of coronary heart disease and angina pectoris and improve the performance of electrocardiograph. At the same time, it can reduce the cardiovascular regulatory peptide ET and increase the level of cGRP in the patient’s plasma, thus confirming its effectiveness and safety.